Guidance

Applying for a Certificate of Pharmaceutical Product after Brexit

Applying for a Certificate of Pharmaceutical Product (CPP) if there's a no-deal Brexit.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 8 April 2019
• Last updated: 9 October 2019 — See all updates

This guidance was withdrawn on 31 January 2020

For current information on Certificate of Pharmaceutical Products see Clinical Trials for Medicines

The way you apply for a Certificate of Pharmaceutical Product (CPP) will not change if there’s a no-deal Brexit.

There will be an extra step in the process if you want to apply for a CPP for something that’s currently a centrally authorised product (CAP).

Get a CPP for a centrally authorised product after Brexit

You’ll need to submit data about the product you’re applying for at least 2 days before you make your CPP application.

You must also email exports@mhra.gov.uk to let them know when you’re about to make your first CPP application. You only need to do this once.

Published 8 April 2019
Last updated 9 October 2019 + show all updates

1. 9 October 2019

   Change of text within Stay up to date box.

2. 26 September 2019

   Clarified that the way you apply for a CPP will not change if there's a no-deal Brexit - but that there are some extra steps before you apply for a CPP for a centrally authorised product.

3. 8 April 2019

   First published.